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ABSTRACT  
Background: The determination of branched chain amino acids (BCAA) to tyrosine ratio (BTR) was  
available in making differentiation of chronic hepatitis from liver cirrhosis, because there was a strong  
association between BTR and staging (fibrosis) scores. Branched chain amino acids to tyrosine ratio have  
a correlation with Fischer ratio and the examination is easier because it can be done by enzymatic assay.  
Materials and Methods: To evaluate the correlation between BTR and Child-Pugh score, we examined the 
amino gram of 52 liver cirrhosis patients consisted of 26 Child-Pugh A, 19 Child-Pugh B, and 7 ChildPugh C. 
The examination of amino gram was done by High Pressure Liquid Chromatograph (HPLC) analyzer. Branched 
chain amino acids to tyrosine ratio were compared to Child-Pugh score, albumin, ammonia level, number 
connection test to Fischer ratio.  
Results: Significant differences in BTR among Child-Pugh A, B, C were observed (Child-Pugh A 7.75 + 1.2; 
Child Pugh B 6.0 + 1.23 and Child Pugh C 4.38 + 3.14 (p = 0.000)). Branched chain amino acids to tyrosine ratio 
had a weak correlation with albumin (r = 0.292; p = 0.036), ammonia level (r = 0.376; p = 0.006) and strong 
correlation with Fischer ratio (r = 0.818; p = 0.000). There was no significant correlation between BTR and number 
connection test.  
Conclusion: These results showed that the determination of the molar ratio of branched chain amino acids  
to tyrosine well reflected the severity of liver cirrhosis and it can be used as a substitute of Fischer ratio.  
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INTRODUCTION 
Metabolic disorders in patients with chronic liver 
disease are commonly accompanied by significant 
changes in amino acid level in blood. The ratio of branched 
chain amino acid (BCAA) and aromatic amino acid 
(AAA) known also as Fischer ratio will decrease in 
accordance with severity of liver disease. This ratio has 
already been decreased in chronic hepatitis and will be 
lower in liver cirrhosis.1,2 
Fischer ratio is not a widely routine examination  
because amino acid measurement takes much longer time  
and expensive. For the last few years, it had been found  
that ratio of BCAA and  branched chain amino acids to  
tyrosine ratio (BTR) had strong correlation with Fischer  
ratio. The procedure may be conducted more rapidly by 
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examining ratio of BCAA and tyrosine, without 
measuring phenylalanine. This is possible because 
the analysis is conducted by enzymatic method which takes 
only few minutes to obtain the results.3,4 
Several studies reported that BTR can be a good  
indicator to evaluate disease severity in liver and had  
replaced BRCA-AAA ratio in making diagnosis and  
management of liver disease.4,5,6 Study of BTR at  
different level of severity of liver cirrhosis had never been  
conducted. This study aims to evaluate BTR at  
different level of severity of liver cirrhosis according to  
Child-Pugh criteria. 
1  
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SUBJECT AND METHODS  
Subjects were patients with liver cirrhosis who had  
been hospitalized in Cipto Mangunkusumo Hospital,  
Jakarta. Diagnosis of liver cirrhosis was made based on  
physical examination, serologic marker of viral hepatitis  
B and or C, abdominal ultrasound with or without liver  
biopsy. Patients aged between 20 and 70 years old and  
were capable to do number connection test (NCT).  
Patients with hepatic encephalopathy grade III, IV or  
evidence of hepatoma or receiving albumin treatment were  
excluded from this study.  
Ammonia level in the serum was examined using  
Du Pont ACA apparatus discrete clinical analyzer with 
wave length of 340 nm and temperature of 37oC. Amino 
acid level was examined by Shimatzu Du Pont High 
Pressure Liquid Chromatograph (HPLC) analyzer at 
temperature of 55oC. 
Data was analyzed with program SPSS. Correlation 
of BTR with Child-Pugh criteria, RF, albumin, ammonia 
and NCT was calculated using Pearson’s correlation test 
based on significance level p < 0.05. 
 
RESULT 
Of 52 patients who fulfilled inclusion criteria, there were 
26 patients with Child-Pugh A, 19 patients with Child- 
Pugh B and 7 patients with Child-Pugh C. Table 1 
describes the characteristic of study subjects. 
 
 
 
 
 
 
 
 
 
 
Mean value of BTR was 6.52 ± 0.85, and it tended to 
be lower in more severe liver cirrhosis. Mean of BTR in 
Child-Pugh A was 7.75 ± 1.2, Child-Pugh 6.0 ± 1.23 and 
Child-Pugh C was 4.38 ± 3.14, and result of statistical 
calculation found correlation r = 0.4914 (p = 0.000).  
 Albumin and Child-Pugh criteria was correlated with  
r = 0.671 (p = 0.000). Ratio of BCAA and tyrosine had 
strong correlation with Fischer ratio. 
BTR and albumin apparently demonstrated a weak 
correlation (r = 0.292, p = 0.036) and the same result was 
also seen between ammonia and BTR (r = 0.376, p 
= 0.006). It appears that NCT which was widely used as 
simple tool for evaluation of hepatic encephalopathy had 
no correlation with BTR. 
Figure 1.  BTR according to Child Pugh Criteria 
Figure 2. Correlation between BTR and Fischer Ratio 
DISCUSSION 
BTR measurement in the previous studies was  
considered useful in assessment of liver disease  
severity. BTR value was found different among normal  
people, patients with acute hepatitis, chronic hepatitis, and  
liver cirrhosis. This study had demonstrated  
significant level of BTR according to Child-Pugh  
criteria. More severe liver cirrhosis had lower BTR. This  
result was in accordance to study conducted by Tameda  
et al which found higher level of BTR in decompensate  
liver cirrhosis compare to non-decompensate  (4.0 ± 1.7  
vs. 2.9 ± 1.2). This was due by increasing level of 
aromatic amino acid (AAA) like phenylalanine, tyrosine 
and thryptophane because they were less degraded in 
the liver. On the other hand, AARC (valin, leucine, and 
isoleucine) were decreased due by increasing catabolism in 
the muscle as consequence of hyperinsulinemia and 
insulin resistance.1,6  
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Table 1. Subject Characteristics 
 Child-
Pugh A 
Child-
Pugh B 
Child-
Pugh C 
Number of patients 26 19 7 
Albumin level (g/dL) 4.2731 3.3579 2.3857 
Ammonia level 
(mmol/L) 
48.6154 54.2105 126.7143 
NCT (second) 69.1540 90.6316 81.4286 
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Correlation between BTR and Child-Pugh criteria was 
weak compare to BTR and albumin. Tameda also reported 
the same result when he compared these two kind 
examinations to differentiate chronic hepatitis and liver 
cirrhosis. It indicated that albumin level was more 
superior than BTR in assessment of liver disease severity in 
chronic hepatitis as well as cirrhosis according to Child- 
Pugh criteria A,B, and C.6 
BTR had strong correlation with Fischer ratio. This  
result was supported by studies conducted by Abe et al  
and Nakamura et al. This had proved that examination of  
BTR level using enzymatic method may be an alternative  
procedure to Fischer ratio which was more expensive and  
complicated.4,5 
BTR had merely weak correlation with albumin and  
ammonia level and appeared had no correlation with NCT.  
This result might due to different factors that influence  
level of albumin, amino acid and ammonia. It found no  
correlation between BTR and NCT. This result supported  
Morgan who concluded that ratio of BCAA and AAA  
had stronger correlation with liver disease severity  
regardless the presence of hepatic encephalopathy.7,8 
 
CONCLUSION 
1.  Ratio of BCAA and tyrosine may be used to  
 replace Fischer ratio 
2.  Decrease ratio of BCAA and tyrosine is in  
 accordance with severity of liver cirrhosis 
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